These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34960048)

  • 1. Associations of Serum Magnesium with Brain Morphology and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities-Neurocognitive Study.
    Alam AB; Thomas DS; Lutsey PL; Shrestha S; Alonso A
    Nutrients; 2021 Dec; 13(12):. PubMed ID: 34960048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial Fibrillation, Brain Volumes, and Subclinical Cerebrovascular Disease (from the Atherosclerosis Risk in Communities Neurocognitive Study [ARIC-NCS]).
    Moazzami K; Shao IY; Chen LY; Lutsey PL; Jack CR; Mosley T; Joyner DA; Gottesman R; Alonso A
    Am J Cardiol; 2020 Jan; 125(2):222-228. PubMed ID: 31771759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of abnormal p-wave parameters with brain MRI morphology: The atherosclerosis risk in communities neurocognitive study (ARIC-NCS).
    Reyes JL; Norby FL; Ji Y; Wang W; Parikh R; Zhang MJ; Oldenburg NC; Lutsey PL; Jack CR; Johansen M; Gottesman RF; Coresh J; Mosley T; Soliman EZ; Alonso A; Chen LY
    Pacing Clin Electrophysiol; 2023 Aug; 46(8):951-959. PubMed ID: 36924350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetes, Prediabetes, and Brain Volumes and Subclinical Cerebrovascular Disease on MRI: The Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS).
    Schneider ALC; Selvin E; Sharrett AR; Griswold M; Coresh J; Jack CR; Knopman D; Mosley T; Gottesman RF
    Diabetes Care; 2017 Nov; 40(11):1514-1521. PubMed ID: 28916531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid Hormone and Subclinical Cerebrovascular Disease: The Atherosclerosis Risk in Communities Brain Magnetic Resonance Imaging Study.
    Korada SK; Zhao D; Gottesman RF; Guallar E; Lutsey PL; Alonso A; Sharrett AR; Post WS; Reis JP; Mosley TH; Michos ED
    J Stroke Cerebrovasc Dis; 2016 Apr; 25(4):883-93. PubMed ID: 26825350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and subclinical cerebrovascular disease: the Atherosclerosis Risk in Communities brain magnetic resonance imaging study.
    Michos ED; Carson KA; Schneider AL; Lutsey PL; Xing L; Sharrett AR; Alonso A; Coker LH; Gross M; Post W; Mosley TH; Gottesman RF
    JAMA Neurol; 2014 Jul; 71(7):863-71. PubMed ID: 24861877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Exhaled Carbon Monoxide With Stroke Incidence and Subclinical Vascular Brain Injury: Framingham Heart Study.
    Nayor M; Enserro DM; Beiser AS; Cheng S; DeCarli C; Vasan RS; Seshadri S
    Stroke; 2016 Feb; 47(2):383-9. PubMed ID: 26696648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).
    Hudson BI; Moon YP; Kalea AZ; Khatri M; Marquez C; Schmidt AM; Paik MC; Yoshita M; Sacco RL; DeCarli C; Wright CB; Elkind MS
    Atherosclerosis; 2011 May; 216(1):192-8. PubMed ID: 21316677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain volumes and cerebrovascular lesions on MRI in patients with atherosclerotic disease. The SMART-MR study.
    Geerlings MI; Appelman AP; Vincken KL; Algra A; Witkamp TD; Mali WP; van der Graaf Y;
    Atherosclerosis; 2010 May; 210(1):130-6. PubMed ID: 19945704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
    Wright CB; Shah NH; Mendez AJ; DeRosa JT; Yoshita M; Elkind MS; Sacco RL; DeCarli C; Rundek T; Silverberg S; Dong C; Wolf M
    Stroke; 2016 Apr; 47(4):923-8. PubMed ID: 26956260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lung Function and Brain MRI Outcomes in the Atherosclerosis Risk in Communities Neurocognitive Study.
    Shrestha S; Zhu X; Sullivan KJ; Simino J; Lutsey PL; Gottesman RF; London SJ; Griswold ME; Mosley TH
    J Alzheimers Dis; 2024; 100(1):297-308. PubMed ID: 38848187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin and Midregional Proatrial Natriuretic Peptide as Biomarkers of Subclinical Cerebrovascular Damage: The Northern Manhattan Study.
    Katan M; Moon Y; von Eckardstein A; Spanaus K; DeRosa J; Gutierrez J; DeCarli C; Wright C; Sacco R; Elkind M
    Stroke; 2017 Mar; 48(3):604-610. PubMed ID: 28123058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study.
    Russo C; Jin Z; Liu R; Iwata S; Tugcu A; Yoshita M; Homma S; Elkind MS; Rundek T; Decarli C; Wright CB; Sacco RL; Di Tullio MR
    JACC Cardiovasc Imaging; 2013 Mar; 6(3):313-23. PubMed ID: 23473112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Cardiovascular Health Across Midlife and Late-Life and Magnetic Resonance Imaging Markers of Cerebral Vascular Disease in Late-Life.
    Sedaghat S; Ji Y; Empana JP; Hughes TM; Mosley TH; Gottesman RF; Griswold M; Jack CR; Lutsey PL; van Sloten TT
    Stroke; 2023 May; 54(5):1280-1288. PubMed ID: 36951053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme deep white matter hyperintensity volumes are associated with African American race.
    Nyquist PA; Bilgel MS; Gottesman R; Yanek LR; Moy TF; Becker LC; Cuzzocreo J; Prince J; Yousem DM; Becker DM; Kral BG; Vaidya D
    Cerebrovasc Dis; 2014; 37(4):244-50. PubMed ID: 24686322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measures of brain morphology and infarction in the framingham heart study: establishing what is normal.
    DeCarli C; Massaro J; Harvey D; Hald J; Tullberg M; Au R; Beiser A; D'Agostino R; Wolf PA
    Neurobiol Aging; 2005 Apr; 26(4):491-510. PubMed ID: 15653178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbleeds, lacunar infarcts, white matter lesions and cerebrovascular reactivity -- a 7 T study.
    Conijn MM; Hoogduin JM; van der Graaf Y; Hendrikse J; Luijten PR; Geerlings MI
    Neuroimage; 2012 Jan; 59(2):950-6. PubMed ID: 21930217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum magnesium and the incidence of coronary artery disease over a median 27 years of follow-up in the Atherosclerosis Risk in Communities (ARIC) Study and a meta-analysis.
    Rooney MR; Alonso A; Folsom AR; Michos ED; Rebholz CM; Misialek JR; Chen LY; Dudley S; Lutsey PL
    Am J Clin Nutr; 2020 Jan; 111(1):52-60. PubMed ID: 31622458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choline and its metabolites are differently associated with cardiometabolic risk factors, history of cardiovascular disease, and MRI-documented cerebrovascular disease in older adults.
    Roe AJ; Zhang S; Bhadelia RA; Johnson EJ; Lichtenstein AH; Rogers GT; Rosenberg IH; Smith CE; Zeisel SH; Scott TM
    Am J Clin Nutr; 2017 Jun; 105(6):1283-1290. PubMed ID: 28356272
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of regional white matter lesions on cognitive function in subcortical vascular cognitive impairment.
    Ai Q; Pu YH; Sy C; Liu LP; Gao PY
    Neurol Res; 2014 May; 36(5):434-43. PubMed ID: 24641691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.